About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Diabetes Technology & Therapeutics

Editor-in-Chief: Satish K. Garg, MD

ISSN: 1520-9156 • Published Monthly • Online ISSN: 1557-8593

Current Volume: 16

Latest Impact Factor* is 2.205

*2012 Journal Citation Reports® published by Thomson Reuters, 2013

Manuscript Submission

STATEMENT OF PURPOSE AND POLICY


Diabetes Technology & Therapeutics will accept original papers and reviews about the use of technology and products to treat, diagnose, and prevent diabetes. Manuscripts submitted to Diabetes Technology & Therapeutics must not contain material that has been reported elsewhere (except in the form of an abstract published for a scientific meeting) or be under consideration for publication elsewhere. Prior abstracts should be described in a footnote to the title. 
 

Diabetes Technology & Therapeutics is a rapid publication journal.  Articles are published online ahead of print in 3-4 weeks.


PLEASE READ ALL THE INSTRUCTIONS TO AUTHORS BEFORE SUBMITTING.

All manuscripts must be submitted online at http://mc.manuscriptcentral.com/diabetestechnology
 

PREPARATION OF MANUSCRIPT 

Prepare manuscripts double-spaced.  Leave ample margins on both sides, top and bottom.

Word limits are as follows:

  • Original paper:  5000 words, each table or figure accounts for 400 words.
  • Invited paper or review articles:   6000 words with no more than 2-3 tables or figures.
  • Brief reports:  1500-2000 words, plus 1 table and 1 figure.
  • Invited editorials: 1,500 words, with no more than 1 table or figure, and up to 30 references.

A title page should be part of your main text file and should  include all authors’ names and affiliations, the funding source (if appropriate), and a running title of up to 45 characters.  Please indicate the name, address, phone number, fax number, and e-mail address of the author to whom reprint requests should be addressed.


Include a minimum of five keywords on the title page to facilitate the review process.
 

The abstract should be no more than 250 words. Abstracts of original papers should contain four paragraphs labeled as: Background, Methods, Results, and Conclusions. Abstracts of reviews should contain a single unlabeled paragraph.

Disclosure Statement

Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.”

In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision.

Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance.

If no conflicts exist, the authors must state “No competing financial interests exist.

TABLES AND ILLUSTRATIONS

Tables should be prepared in Word and be supplied in a separate file from the text.  Use Arabic numerals to number tables. Each table must stand alone, i.e., contain all necessary information in the caption, and the table itself must be understood independently of the text. Details of experimental conditions should be included in the table footnotes. Information that appears in the text should not be repeated in the table, and tables should not contain data that can be given in the text in one or two sentences.  Each supplied table must have a title.

Please submit artwork according to the following guidelines:
 

Please follow these guidelines for submitting artwork:

• Do NOT embed art files into a Word or PDF document.
• Line illustrations should be submitted at  900 dpi.
• Halftones and color should be submitted at a minimum of 300 dpi.
• Save as either TIFF or EPS files.
• Color art must be saved as CYMK - not RGB.
• Black and White art must be submitted as grayscale – not RGB.
• Do NOT submit PowerPoint, PDF, Bitmap or Excel files.

Please name your artwork files with the submitting authors name i.e. SmithFig1.tif, SmithTable2.tif etc.  Authors who do not follow these guidelines may have their submission returned to them without being reviewed.

ADDITIONAL INFORMATION ABOUT ART FILES

Converting Word or Excel files:  Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
 

• All files should be scanned at 100% size.
• 300 dpi
• Final color mode: cmyk
• save file as: .tif or .eps
 
If you need directions on how to convert a Power Point slide to acceptable format go to http://www.liebertpub.com/MEDIA/pdf/ppconvert.pdf  

AUTHOR DISCLOSURE

All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript. Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultantships, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should be disclosed in the Acknowledgments section.

REFERENCES

List references in consecutive numerical order (not alphabetically). All subsequent reference citations should be to the original number.  Cite all references in the text or tables. Unpublished data and personal communications should not be listed as references.  Abbreviations of journal titles should follow MEDLINE.


References to journal papers should include: (1) author(s) (list the first three authors, followed by et al. if applicable), (2) title, (3) journal name (as abbreviated in MEDLINE), (4) year, (5) volume number, and 6) inclusive page numbers, in that order.
 

References to books should include: (1) author(s), (2) chapter title (if any), (3) editor (if any), (4) title of book, (5) city of publication, (6) publisher, and (7) year. Volume and edition numbers, specific pages, and name of translator should be included when appropriate. The author is responsible for the accuracy and completeness of the references and for their correct text citation.

AUTHORSHIP

It is the submitting author’s responsibility to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the paper. Once a paper is accepted for publication, changes in authorship while the paper is in production – including page proofs – are NOT permitted. Changes in authorship after publication are strictly prohibited.

PATIENT RELEASE INFORMATION

If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images of patients.  The submitting author should provide written confirmation of this critical information.  Acceptable forms of consent statements are emails or letters.  The Journal does not provide a generic patient release form.

The written consent must contain specific information about the patient's name, age, and if pertinent, conservatorship -- as well as stated permission -- granting the Journal the rights to publish the photograph within its pages (which includes the name of the Journal and article title).  

PERMISSIONS

The author must obtain permission to reproduce figures, tables and text from previously published material. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned. An appropriate credit line should be included in the figure or legend or table footnote, and full publication information should be included in the reference list. Written permission must be obtained from the author of any unpublished material and should accompany the manuscript.

REPRINTS

Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

PUBLISHER

The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: 914-740-2100; fax: 914-740-2101. E-mail: info@liebertpub.com Online: www.liebertpub.com 

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Metabolic Syndrome
    and Related Disorders

    Metabolic Syndrome
    and Related Disorders

    The only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition.

    Childhood Obesity

    Childhood Obesity

    Explores effective, actionable strategies for weight management and obesity prevention in children and adolescents, with in-depth coverage on education, policy, health disparities and cultural sensitivities, and more.

    Population Health Management

    Population Health Management

    Comprehensive, authoritative strategies for improving the systems and policies that affect health care quality, access, and outcomes, ultimately improving the health of an entire population.

Browse All Publications »


ATTD launches brand new Diabetes Technology Connection newsletter!